Cargando…

Biomarkers of Cholestasis and Liver Injury in the Early Phase of Acute Respiratory Distress Syndrome and Their Pathophysiological Value

Background: Impaired liver function and cholestasis are frequent findings in critically ill patients and are associated with poor outcomes. We tested the hypothesis that hypoxic liver injury and hypoxic cholangiocyte injury are detectable very early in patients with ARDS, may depend on the severity...

Descripción completa

Detalles Bibliográficos
Autores principales: Harnisch, Lars-Olav, Baumann, Sophie, Mihaylov, Diana, Kiehntopf, Michael, Bauer, Michael, Moerer, Onnen, Quintel, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699895/
https://www.ncbi.nlm.nih.gov/pubmed/34943592
http://dx.doi.org/10.3390/diagnostics11122356
_version_ 1784620624626319360
author Harnisch, Lars-Olav
Baumann, Sophie
Mihaylov, Diana
Kiehntopf, Michael
Bauer, Michael
Moerer, Onnen
Quintel, Michael
author_facet Harnisch, Lars-Olav
Baumann, Sophie
Mihaylov, Diana
Kiehntopf, Michael
Bauer, Michael
Moerer, Onnen
Quintel, Michael
author_sort Harnisch, Lars-Olav
collection PubMed
description Background: Impaired liver function and cholestasis are frequent findings in critically ill patients and are associated with poor outcomes. We tested the hypothesis that hypoxic liver injury and hypoxic cholangiocyte injury are detectable very early in patients with ARDS, may depend on the severity of hypoxemia, and may be aggravated by the use of rescue therapies (high PEEP level and prone positioning) but could be attenuated by extracorporeal membrane oxygenation (ECMO). Methods: In 70 patients with ARDS, aspartate-aminotransferase (AST), alanin-aminotransferase (ALT) and gamma glutamyltransferase (GGT) were measured on the day of the diagnosis of ARDS and three more consecutive days (day 3, day 5, day 10), total bile acids were measured on day 0, 3, and 5. Results: AST levels increased on day 0 and remained constant until day 5, then dropped to normal on day 10 (day 0: 66.5 U/l; day 3: 60.5 U/l; day 5: 63.5 U/l, day 10: 32.1 U/l), ALT levels showed the exact opposite kinetic. GGT was already elevated on day 0 (91.5 U/l) and increased further throughout (day 3: 163.5 U/l, day 5: 213 U/l, day 10: 307 U/l), total bile acids levels increased significantly from day 0 to day 3 (p = 0.019) and day 0 to day 5 (p < 0.001), but not between day 3 and day 5 (p = 0.217). Total bile acids levels were significantly correlated to GGT on day 0 (p < 0.001), day 3 (p = 0.02), and in a trend on day 5 (p = 0.055). PEEP levels were significantly correlated with plasma levels of AST (day 3), ALT (day 5) and GGT (day 10). Biomarker levels were not associated with the use of ECMO, prone position, the cause of ARDS, and paO(2). Conclusions: We found no evidence of hypoxic liver injury or hypoxic damage to cholangiocytes being caused by the severity of hypoxemia in ARDS patients during the very early phase of the disease. Additionally, mean PEEP level, prone positioning, and ECMO treatment did not have an impact in this regard. Nevertheless, GGT levels were elevated from day zero and rising, this increase was not related to paO(2), prone position, ECMO treatment, or mean PEEP, but correlated to total bile acid levels.
format Online
Article
Text
id pubmed-8699895
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86998952021-12-24 Biomarkers of Cholestasis and Liver Injury in the Early Phase of Acute Respiratory Distress Syndrome and Their Pathophysiological Value Harnisch, Lars-Olav Baumann, Sophie Mihaylov, Diana Kiehntopf, Michael Bauer, Michael Moerer, Onnen Quintel, Michael Diagnostics (Basel) Article Background: Impaired liver function and cholestasis are frequent findings in critically ill patients and are associated with poor outcomes. We tested the hypothesis that hypoxic liver injury and hypoxic cholangiocyte injury are detectable very early in patients with ARDS, may depend on the severity of hypoxemia, and may be aggravated by the use of rescue therapies (high PEEP level and prone positioning) but could be attenuated by extracorporeal membrane oxygenation (ECMO). Methods: In 70 patients with ARDS, aspartate-aminotransferase (AST), alanin-aminotransferase (ALT) and gamma glutamyltransferase (GGT) were measured on the day of the diagnosis of ARDS and three more consecutive days (day 3, day 5, day 10), total bile acids were measured on day 0, 3, and 5. Results: AST levels increased on day 0 and remained constant until day 5, then dropped to normal on day 10 (day 0: 66.5 U/l; day 3: 60.5 U/l; day 5: 63.5 U/l, day 10: 32.1 U/l), ALT levels showed the exact opposite kinetic. GGT was already elevated on day 0 (91.5 U/l) and increased further throughout (day 3: 163.5 U/l, day 5: 213 U/l, day 10: 307 U/l), total bile acids levels increased significantly from day 0 to day 3 (p = 0.019) and day 0 to day 5 (p < 0.001), but not between day 3 and day 5 (p = 0.217). Total bile acids levels were significantly correlated to GGT on day 0 (p < 0.001), day 3 (p = 0.02), and in a trend on day 5 (p = 0.055). PEEP levels were significantly correlated with plasma levels of AST (day 3), ALT (day 5) and GGT (day 10). Biomarker levels were not associated with the use of ECMO, prone position, the cause of ARDS, and paO(2). Conclusions: We found no evidence of hypoxic liver injury or hypoxic damage to cholangiocytes being caused by the severity of hypoxemia in ARDS patients during the very early phase of the disease. Additionally, mean PEEP level, prone positioning, and ECMO treatment did not have an impact in this regard. Nevertheless, GGT levels were elevated from day zero and rising, this increase was not related to paO(2), prone position, ECMO treatment, or mean PEEP, but correlated to total bile acid levels. MDPI 2021-12-14 /pmc/articles/PMC8699895/ /pubmed/34943592 http://dx.doi.org/10.3390/diagnostics11122356 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Harnisch, Lars-Olav
Baumann, Sophie
Mihaylov, Diana
Kiehntopf, Michael
Bauer, Michael
Moerer, Onnen
Quintel, Michael
Biomarkers of Cholestasis and Liver Injury in the Early Phase of Acute Respiratory Distress Syndrome and Their Pathophysiological Value
title Biomarkers of Cholestasis and Liver Injury in the Early Phase of Acute Respiratory Distress Syndrome and Their Pathophysiological Value
title_full Biomarkers of Cholestasis and Liver Injury in the Early Phase of Acute Respiratory Distress Syndrome and Their Pathophysiological Value
title_fullStr Biomarkers of Cholestasis and Liver Injury in the Early Phase of Acute Respiratory Distress Syndrome and Their Pathophysiological Value
title_full_unstemmed Biomarkers of Cholestasis and Liver Injury in the Early Phase of Acute Respiratory Distress Syndrome and Their Pathophysiological Value
title_short Biomarkers of Cholestasis and Liver Injury in the Early Phase of Acute Respiratory Distress Syndrome and Their Pathophysiological Value
title_sort biomarkers of cholestasis and liver injury in the early phase of acute respiratory distress syndrome and their pathophysiological value
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699895/
https://www.ncbi.nlm.nih.gov/pubmed/34943592
http://dx.doi.org/10.3390/diagnostics11122356
work_keys_str_mv AT harnischlarsolav biomarkersofcholestasisandliverinjuryintheearlyphaseofacuterespiratorydistresssyndromeandtheirpathophysiologicalvalue
AT baumannsophie biomarkersofcholestasisandliverinjuryintheearlyphaseofacuterespiratorydistresssyndromeandtheirpathophysiologicalvalue
AT mihaylovdiana biomarkersofcholestasisandliverinjuryintheearlyphaseofacuterespiratorydistresssyndromeandtheirpathophysiologicalvalue
AT kiehntopfmichael biomarkersofcholestasisandliverinjuryintheearlyphaseofacuterespiratorydistresssyndromeandtheirpathophysiologicalvalue
AT bauermichael biomarkersofcholestasisandliverinjuryintheearlyphaseofacuterespiratorydistresssyndromeandtheirpathophysiologicalvalue
AT moereronnen biomarkersofcholestasisandliverinjuryintheearlyphaseofacuterespiratorydistresssyndromeandtheirpathophysiologicalvalue
AT quintelmichael biomarkersofcholestasisandliverinjuryintheearlyphaseofacuterespiratorydistresssyndromeandtheirpathophysiologicalvalue